Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 44,670,000 shares, an increase of 13.2% from the December 31st total of 39,460,000 shares. Based on an average daily volume of 10,740,000 shares, the days-to-cover ratio is currently 4.2 days. Currently, 18.5% of the company’s stock are short sold.
Analyst Ratings Changes
Several brokerages have recently issued reports on CORZ. HC Wainwright raised their price target on Core Scientific from $15.00 to $17.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Keefe, Bruyette & Woods assumed coverage on Core Scientific in a research report on Monday, January 27th. They set an “outperform” rating and a $22.00 target price on the stock. Roth Capital raised Core Scientific to a “strong-buy” rating in a report on Thursday, November 14th. Roth Mkm assumed coverage on Core Scientific in a report on Friday, November 15th. They set a “buy” rating and a $25.50 price objective on the stock. Finally, Compass Point lifted their price objective on Core Scientific from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Fifteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Core Scientific has a consensus rating of “Buy” and an average price target of $19.07.
Get Our Latest Stock Report on Core Scientific
Insider Buying and Selling at Core Scientific
Institutional Trading of Core Scientific
A number of institutional investors have recently bought and sold shares of CORZ. Sunbelt Securities Inc. acquired a new stake in Core Scientific during the 2nd quarter worth $33,000. Newbridge Financial Services Group Inc. acquired a new stake in Core Scientific during the 4th quarter worth $42,000. Rise Advisors LLC grew its holdings in Core Scientific by 14.3% during the 3rd quarter. Rise Advisors LLC now owns 8,000 shares of the company’s stock worth $95,000 after acquiring an additional 1,000 shares during the period. KBC Group NV acquired a new stake in Core Scientific during the 4th quarter worth $114,000. Finally, Arkadios Wealth Advisors acquired a new stake in Core Scientific during the 3rd quarter worth $119,000.
Core Scientific Stock Down 3.0 %
CORZ stock traded down $0.36 during trading on Monday, hitting $11.91. The company had a trading volume of 5,390,002 shares, compared to its average volume of 12,620,471. The firm has a 50-day moving average price of $15.03 and a 200-day moving average price of $13.04. Core Scientific has a 12 month low of $2.61 and a 12 month high of $18.63. The stock has a market cap of $3.33 billion and a price-to-earnings ratio of -2.20.
Core Scientific (NASDAQ:CORZ – Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.02). The company had revenue of $95.35 million for the quarter, compared to analysts’ expectations of $94.80 million. Equities analysts expect that Core Scientific will post 0.5 EPS for the current year.
Core Scientific Company Profile
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Featured Stories
- Five stocks we like better than Core Scientific
- Why Invest in High-Yield Dividend Stocks?
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
- How to trade using analyst ratings
- Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts
- What is the Australian Securities Exchange (ASX)
- Procter & Gamble: A Consumer Staples Titan Built to Win
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.